Cancer
Association of genetic polymorphism of glutathione S-transferases with colorectal cancer susceptibility in snuff (Naswar) addicts
The current study aimed to investigate the relationship between polymorphisms in detoxifying (GSTM1, GSTT1, and GSTP1) genes and their association ...
Black, Hispanic Patients Less Likely To Get Lifesaving Liver Cancer Treatment
Photos: Cedars-Sinai
Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most eff...
Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity
Purpose:
Stereotactic ablative radiotherapy (SABR) has demonstrated clinical benefit in oligometastatic prostate cancer. However, th...
Do Minority Patients Receive the Same Quality of Cancer Care?
Cancer is a jarring and potentially sensitive subject, and that requires asking hard, even uncomfortable questions — especially when it comes to th...
How structural, medical racism perpetuates Asian American cancer disparities
When Susan Shinagawa found a pea-sized lump in her right breast, she said her doctor refused to diagnose her with cancer because, she recalled him ...
African American Prostate Cancer Patients Get More VUS, Fewer Actionable Results, Studies Show
NEW YORK – African American men with prostate cancer are receiving more limited germline genetic testing for cancer risk and getting more uncertain...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
